We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Brown-Forman Class B
BF.B
$11.8B
| $109K | ﹤0.01% |
1,497
-436
| -23% | -$31K |
|
1702
Under Armour Class C
UA
$2.09B
| $109K | ﹤0.01% |
6,055
+221
| +4% | +$4.29K |
|
1703
Wabtec
WAB
$46.7B
| $105K | ﹤0.01% |
1,139
-57
| -5% | -$5.23K |
|
1704
JB Hunt Transport Services
JBHT
$22.2B
| $104K | ﹤0.01% |
510
+3
| +0.6% | +$577 |
|
|
VIRX
1705
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $104K | ﹤0.01% |
+28,582
| New | +$153K |
|
|
SMED
1706
DELISTED
Sharps Compliance Corp
SMED
| $103K | ﹤0.01% |
+14,458
| New | +$111K |
|
1707
Boston Properties
BXP
$10.2B
| $102K | ﹤0.01% |
886
-186
| -17% | -$21.4K |
|
1708
Insight Enterprises
NSIT
$4.85B
| $101K | ﹤0.01% |
947
-548
| -37% | -$54.5K |
|
|
SI
1709
DELISTED
Silvergate Capital Corporation
SI
| $101K | ﹤0.01% |
679
+207
| +44% | +$35.4K |
|
1710
Viatris
VTRS
$19.5B
| $99K | ﹤0.01% |
7,239
-13,995
| -66% | -$187K |
|
1711
Eastman Chemical
EMN
$7.44B
| $98K | ﹤0.01% |
811
-5,367
| -87% | -$597K |
|
|
TDAY
1712
USA Today Co
TDAY
$951M
| $98K | ﹤0.01% |
18,316
+1,611
| +10% | +$8.99K |
|
1713
Rollins
ROL
$16.1B
| $95K | ﹤0.01% |
+2,765
| New | +$96.8K |
|
|
APR
1714
DELISTED
Apria, Inc. Common Stock
APR
| $95K | ﹤0.01% |
2,916
-2,683
| -48% | -$87K |
|
1715
Piper Sandler
PIPR
$5.04B
| $91K | ﹤0.01% |
2,036
-3,264
| -62% | -$139K |
|
1716
Carriage Services
CSV
$508M
| $90K | ﹤0.01% |
1,389
-1,762
| -56% | -$91.3K |
|
|
OCDX
1717
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $90K | ﹤0.01% |
4,202
-241,148
| -98% | -$4.75M |
|
1718
Alexandria Real Estate Equities
ARE
$9.21B
| $89K | ﹤0.01% |
397
+46
| +13% | +$9.52K |
|
1719
CorVel
CRVL
$3.6B
| $88K | ﹤0.01% |
1,269
-2,028
| -62% | -$127K |
|
1720
The Mosaic Company
MOS
$7.88B
| $88K | ﹤0.01% |
2,246
+184
| +9% | +$7.04K |
|
1721
Meritage Homes
MTH
$4.17B
| $88K | ﹤0.01% |
1,434
-24
| -2% | -$1.34K |
|
1722
Campbell Soup
CPB
$6.38B
| $87K | ﹤0.01% |
2,002
-372
| -16% | -$15.5K |
|
|
CMPI
1723
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $87K | ﹤0.01% |
30,092
+10,092
| +50% | +$37.6K |
|
1724
AdvanSix
ASIX
$449M
| $86K | ﹤0.01% |
1,835
+912
| +99% | +$42K |
|
1725
DaVita
DVA
$12.4B
| $86K | ﹤0.01% |
759
-89,696
| -99% | -$9.64M |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.